N/A Completed N=10 Randomized Treatment

Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique

Arteriovenous Fistula, Cannulation

Source: ClinicalTrials.gov NCT02814721 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2024

Primary outcomePrimary: Infiltration Due to Dialysis Access Cannulation — 5; 7 infiltration events

Summary

Infiltrations from cannulation difficulties result in significant morbidity including loss of vascular access (VA) loss in hemodialysis (HD). Cannulation is reliant on personnel skill and VA characteristics. Surface marking of VA lacks real-time information and traditional ultrasound (US) devices are large, expensive and require skilled operator expertise. Sonic Window© (Analogic Ultrasound, Peabody, MA) is a coronal mode ultrasound device (CMUD) approved for VA cannulation. Study is a single center randomized, prospective pilot study comparing handheld US-guided cannulation of new arteriovenous fistula (AVF) to standard cannulation practices.

Outcome Measures

Outcome	Result	p-value
PRIMARY Infiltration Due to Dialysis Access Cannulation	5; 7	—
SECONDARY Patient Pain Scale	2.1; 2.6	—

Eligibility Criteria

Inclusion Criteria

End-stage renal disease with new arteriovenous fistula being started for cannulation

Exclusion Criteria

End-stage renal disease with grafts

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02814721). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.